Two Sigma Investments’s Cabaletta Bio CABA Stock Holding History
Bought
Maintained
Sold
Other funds holding CABA
Two Sigma Investments's CABA Position: Q3 2026 in Review
Two Sigma Investments reduced its Cabaletta Bio (CABA) stake by 27% in Q3 2026, selling an estimated $1.05M and leaving 1,036,927 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #3062.
Two Sigma Investments first reported a position in CABA in Q2 2020 and has held it in 26 quarters since. The position peaked at $6.72M in Q1 2026. 163 funds tracked by Wall St. Rank hold CABA as of Q3 2026.
- Two Sigma Investments held 1,036,927 shares of Cabaletta Bio worth $1.99M as of Q3 2026.
- Two Sigma Investments sold 374,004 Cabaletta Bio shares in Q3 2026, an estimated $1.05M.
- Cabaletta Bio made up ﹤0.01% of Two Sigma Investments's portfolio in Q3 2026, its #3062 holding.
- Two Sigma Investments first reported a position in Cabaletta Bio in Q2 2020 and has held it in 26 quarters since.
- Two Sigma Investments's Cabaletta Bio position peaked at $6.72M in Q1 2026.
- 163 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.